Sfoglia per Rivista  CANCER

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostra risultati da 1 a 20 di 55
Titolo Data di pubblicazione Autore(i) File
A pilot study of suramin in the treatment of metastatic renal cell carcinoma 1-gen-1991 LA ROCCA, Rv; Stein, Ca; Danesi, Romano; Cooper, Mr; Uhrich, M; Myers, Ce
A rational postoperative follow-up with carcinoembryonic antigen, tissue polypeptide antigen, and urinary hydroxyproline in breast cancer patients 1-gen-1989 Nicolini, A; Carpi, Angelo; Di Marco, G; Giuliani, L; Giordani, R; Palla, S.
Alpha-2B-Interferon plus floxuridine in metastatic renal cell carcinoma: a phase I-II study 1-gen-1993 Falcone, Alfredo; C., Cianci; S., Ricci; I., Brunetti; M., Bertuccelli; Pf, Conte
Azacitidine for the treatment of lower risk myelodysplastic syndromes: A retrospective study of 74 patients enrolled in an Italian named patient program 1-gen-2010 Musto, Pellegrino; Maurillo, Luca; Spagnoli, Alessandra; Gozzini, Antonella; Rivellini, Flavia; Lunghi, Monia; Villani, Oreste; Aloe Spiriti, Maria Antonietta; Venditti, Adriano; Santini, Valeria; Leone, Giuseppe; Voso, Maria Teresa; D'Arco, Alfonso Maria; Tatarelli, Caterina; Ferrero, Dario; Gaidano, Gianluca; Palumbo, Giuseppe; Di Raimondo, Francesco; Oliva, Esther; Sanpaolo, Grazia; Tonso, Anna; Santagostino, Alberto; Filardi, Nunzio; Pollio, Berardino; Candoni, Anna; Fili, Carla; Russo, Domenico; Orciuolo, Enrico; Petrini, Mario; Ciuffreda, Lucia; Riezzo, Antonio; Morabito, Fortunato; Mazza, Patrizio; Pastore, Domenico; Specchia, Giorgina; Ferrara, Felicetto
Characterization of Ph-negative abnormal clones emerging during imatinib therapy 1-gen-2007 Abruzzese, E; Gozzetti, A; Galimberti, Sara; Trawinska, Mm; Caravita, T; Siniscalchi, A; Cervetti, G; Mauriello, A; Coletta, Am; DE FABRITIIS, P.
Clinical impact of anti-epidermal growth factor receptor monoclonal antibodies in first-line treatment of metastatic colorectal cancer: Meta-analytical estimation and implications for therapeutic strategies. 1-gen-2012 Loupakis, F; Cremolini, Chiara; Salvatore, L; Schirripa, M; Lonardi, S; Vaccaro, V; Cuppone, F; Giannarelli, D; Zagonel, V; Cognetti, F; Tortora, G; Falcone, Alfredo; Bria, E.
Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer 1-gen-2016 Sherman, Steven I; Clary, Douglas O.; Elisei, Rossella; Schlumberger, Martin J.; Cohen, Ezra E. W.; Schöffski, Patrick; Wirth, Lori J.; Mangeshkar, Milan; Aftab, Dana T.; Brose, Marcia S.
Correlative analysis of gene expression profile and prognosis in patients with gliomatosis cerebri 1-gen-2009 D'Urso, Of; D'Urso, Pi; Marsigliante, S; Storelli, C; Luzi, G; Gianfreda, Cd; Montinaro, A; Distante, Alessandro; Ciappetta, P.
Current status of radiotherapy with proton and light ion beams 1-gen-2007 Greco, Carlo; Wolden, S.
Descriptive epidemiology of intestinal cancer in Italy 1-gen-1988 Cislaghi, C; Decarli, A; Lavecchia, C; Vigotti, MARIA ANGELA
Endothelin-1 in human prostatic carcinoma treated with androgen withdrawal 1-gen-2001 ANNA DE, Matteis; Guidi, Alessandra; BARBARA DI, Paolo; Giorgio, Franco; ROBERTO P., Revoltella
Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck 1-gen-2002 Franchi, A.; Santucci, M.; Masini, E.; Sardi, I.; Paglierani, M.; Gallo, O.
Gemcitabine plus epirubicin in patients with advanced urothelial carcinoma not elegible for platinum-based regimens 1-gen-2002 Ricci, S.; Galli, L.; Chioni, A.; Iannopollo, A.; Antonuzzo, A.; Francesca, F.; Vocaturo, V.; Selli, Cesare; Orlandini, C.; Conte, P. F.
Genetic alterations between primary head and neck squamous cell carcinoma and recurrence after radiotherapy 1-gen-2010 Deganello, A.; Franchi, A.; Sardi, I.; Pignataro, L.; Leemans, Cr.; Gallo, O.
Genetic and epigenetic alteration of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas 1-gen-1998 Elisei, Rossella; Shiohara, M.; Koeffler, H. P.; Fagin, J. A.
High-resolution methylation analysis of the hMLH1 promoter in sporadic endometrial and colorectal carcinomas 1-gen-2003 Strazzullo, M.; Cossu, A.; Baldinu, P.; Colombino, M.; Satta, M. P.; Tanda, F.; De Bonis, M. L.; Cerase, A.; D'Urso, M.; D'Esposito, M.; Palmieri, G.
Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy. Regional mapping of viable and nonviable tumor 1-gen-1985 P., Picci; G., Bacci; M., Campanacci; M., Gasparini; S., Pilotti; S., Cerasoli; F., Bertoni; A., Guerra; Capanna, Rodolfo; U., Albisinni; S., Galletti; F., Gherlinzoni; P., Calderoni; A., Sudanese; N., Baldini; M., Bernini; N., Jaffe
Human neu oncogene is expressed in endometrial but not in ovarian adenocarcinomas. 1-gen-1991 Garuti, G; Genazzani, Andrea
Identification of candidate genes carrying polymorphisms associated with the risk of colorectal cancer by analyzing the colorectal mutome and microRNAome. 1-gen-2012 Landi, D; Gemignani, Federica; Pardini, B; Naccarati, A; Garritano, S; Vodicka, P; Vodickova, L; Canzian, F; Novotny, J; Barale, Roberto; Landi, Stefano
The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria 1-gen-2012 T., Cai; G., Malossini; Bartoletti, Riccardo
Mostra risultati da 1 a 20 di 55
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile